Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Nature’s Sunshine Products ( (NATR) ) is now available.
On June 27, 2025, Fosun Pharma sold a significant portion of its shares in Nature’s Sunshine Products, reducing its ownership below 5%. Consequently, on June 30, 2025, Nature’s Sunshine Products agreed to repurchase Fosun Pharma’s interests in their joint ventures in Hong Kong and Shanghai for a total of $7 million, subject to regulatory approvals in China.
The most recent analyst rating on (NATR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Nature’s Sunshine Products stock, see the NATR Stock Forecast page.
Spark’s Take on NATR Stock
According to Spark, TipRanks’ AI Analyst, NATR is a Outperform.
Nature’s Sunshine Products displays strong financial health, robust cash flow, and a stable balance sheet, contributing to a solid foundation in the packaged foods industry. The stock exhibits positive technical momentum, although it’s nearing overbought levels. Valuation is less attractive due to a high P/E ratio and no dividend yield, but recent earnings results and strategic expansion efforts in key markets provide reasons for optimism. Challenges in North America and macroeconomic uncertainties are noted, but overall, the stock is well-positioned for future growth.
To see Spark’s full report on NATR stock, click here.
More about Nature’s Sunshine Products
Nature’s Sunshine Products, Inc. operates in the health and wellness industry, focusing on the marketing and distribution of nutritional and personal care products. The company has a market focus in China through its joint ventures with Fosun Pharma.
Average Trading Volume: 78,368
Technical Sentiment Signal: Strong Buy
Current Market Cap: $287.8M
For detailed information about NATR stock, go to TipRanks’ Stock Analysis page.